Humulin R 100 iu/ml

Riik: Jordaania

keel: inglise

Allikas: JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

Toimeaine:

Insulin Human 100 iu/ml

Saadav alates:

شركة مستودع الادوية العربي - THE ARAB DRUG STORE P.S.C

ATC kood:

A10AB04

INN (Rahvusvaheline Nimetus):

Insulin Human 100 iu/ml

Annus:

100 iu/ml

Ühikuid pakis:

5 X 3ml cartridges

Valmistatud:

ليلي فرانس (فرنسا)

Toote kokkuvõte:

21.81 :سعر الجمهور + الضريبة

Infovoldik

PA001FSJD00
EUSPC24FEB2012
1.
NAME OF THE MEDICINAL PRODUCT
Humulin N 100 IU/ml suspension for injection in cartridge
Humulin 70/30 100 IU/ml suspension for injection in cartridge
Humulin R 100 IU/ml solution for injection in cartridge
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
1 ml contains 100 IU human insulin (produced in _ E. coli_ by
recombinant DNA
technology).
HUMULIN N
One cartridge contains 3 ml equivalent to 300 IU of isophane insulin.
HUMULIN 70/30
One cartridge contains 3 ml equivalent to 300 IU of biphasic isophane
insulin – 30 %
soluble insulin / 70 % isophane insulin.
HUMULIN R
One cartridge contains 3 ml equivalent to 300 IU of soluble insulin.
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
HUMULIN N
A suspension for injection in a cartridge.
Humulin N is a sterile suspension of a white, crystalline precipitate
of isophane
human insulin in an isotonic phosphate buffer.
HUMULIN 70/30
A suspension for injection in a cartridge.
Humulin 70/30 is a sterile suspension of human insulin in the
proportion of 30 %
soluble insulin to 70 % isophane insulin.
HUMULIN R
A solution for injection in a cartridge.
Humulin R is a sterile, clear, colourless, aqueous solution of human
insulin.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
For the treatment of patients with diabetes mellitus who require
insulin for the
maintenance of glucose homeostasis.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
The dosage should be determined by the physician, according to the
requirement of
the patient.
Subcutaneous administration should be in the upper arms, thighs,
buttocks or
abdomen. Use of injection sites should be rotated so that the same
site is not used
more than approximately once a month.
Care should be taken when injecting any Humulin insulin preparations
to ensure
that a blood vessel has not been entered. After any insulin injection,
the injection
site should not be massaged. Patients must be educated to use proper
injection
techniques.
Each pack contains a patient information leaflet with